Posaconazole Suspension
NDC Package 0254-1016-36
Package Information
Posaconazole suspension is posaconazole delayed-release tablets are indicated for the treatment of invasive aspergillosis in adults and pediatric patients 2 years of age and older who weigh greater than 40 kg. This formulation utilizes a suspension delivery system. Marketed by Endo Usa, Inc., this product is identified by NDC 0254-1016 and is authorized under FDA application NDA022003.
Identification & Billing
- RxCUI: 1482908 - posaconazole 100 MG Delayed Release Oral Tablet
- RxCUI: 665019 - posaconazole 200 MG in 5 mL Oral Suspension
- RxCUI: 665019 - posaconazole 40 MG/ML Oral Suspension
- RxCUI: 665019 - posaconazole 200 MG per 5 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0254 - Endo Usa, Inc.
- 0254-1016 - Posaconazole
- 0254-1016-36 - 1 BOTTLE, GLASS in 1 CARTON / 105 mL in 1 BOTTLE, GLASS
- 0254-1016 - Posaconazole
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0254-1016-36 identifies a specific commercial package of 1 bottle, glass in 1 carton / 105 ml in 1 bottle, glass of Posaconazole, a human prescription drug labeled by Endo Usa, Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 105 billable units per package. This suspension is formulated for oral use and contains posaconazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Endo Usa, Inc. on March 29, 2023. The current certification is valid through December 31, 2027.
How is this Endo Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00254101636. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 105 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.